Cancer Research

A record 383 vials of LYMPHIR were ordered in July, establishing a new performance benchmark for the company’s expanded 29-member nationwide sales infrastructure. This milestone represents a significant pivot for Citius Pharmaceuticals as it transitions from a clinical-stage entity into a

Evidence suggests that neuroinflammation in CAR T-cell patients can persist as a localized metabolic crisis even after systemic inflammatory markers in the bloodstream have been successfully reduced. This finding highlights the complex nature of Chimeric Antigen Receptor (CAR) T-cell therapy, a

A newly developed molecular shield consisting of a positively charged oligopeptide linked to two polyethylene glycol chains can transiently block the entry points of the liver. This innovation addresses a fundamental limitation in the field of genetic medicine, where the immense potential of

The transformation of discarded medical waste into a sophisticated fleet of microscopic couriers capable of delivering life-saving gene therapies directly to tumors represents a fundamental shift in how medicine interacts with the human body. In the current landscape of 2026, the primary challenge

Research into anaplastic thyroid carcinoma suggests that blocking the enzyme PHGDH may effectively close the metabolic escape routes that facilitate resistance to targeted therapies. This aggressive form of thyroid cancer remains one of the most lethal malignancies, characterized by its rapid

Utilizing a Visual-Global Relation Fusion Network enables the discovery of crucial pathological connections that define a patient's biological response to diverse chemotherapy regimens. This breakthrough represents a seismic shift in modern oncology, moving away from the conventional